With over 20% of people born between 1997 and 2003 identifying as a sexual and gender minority, moderated panels at SCOPE 2024 discuss the need to engage this community in clinical trials.
We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for Inclusivity Read More »
La evolución de la vida en la Tierra es una narrativa épica de adaptación y transformación a lo largo de millones de años. Uno de los momentos más trascendentales en esta saga evolutiva es la transición de los seres vivos acuáticos hacia tierra …
La transición de los seres vivos acuáticos hacia tierra firme Read More »
Artificial intelligence and a flood of data in the pharmaceutical industry will likely change some of the current functions of its data scientists, experts say, but the ability to learn and adapt to new technologies will remain key in this role.
Data Analysts Take on Greater Role Amid Data Explosion in Biopharma Read More »
The FDA awarded the designation after seeing evidence the digital cognitive behavioral therapy may help reduce liver fat.
Better Therapeutics wins breakthrough status for health app to treat liver disease Read More »
Enveric Biosciences today announced the discovery of multiple, promising novel compounds sourced using the company’s Psybrary™ platform and proprietary computational chemistry and artificial intelligence (AI) drug-discovery system (PsyAI™).
Lutris Pharma today announced the publication of data from its phase 1/2 trial of lead compound, LUT014, a topically applied, novel B-Raf inhibitor, for the treatment of radiation-induced dermatitis (RD) in patients with breast cancer.
Saghmos Therapeutics, Inc. announced the appointment of Stephen Grant, MD, as Chief Regulatory Officer.
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the “Company”), today reported financial results for the fourth quarter and full year ended December 31, 2023.
Ionis reports fourth quarter and full year 2023 financial results Read More »
Zimmer Biomet Holdings, Inc. today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2024.
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024 Read More »
The research found no differences in 30-day hospital readmissions or mortality, but the study’s authors said more analysis on patients’ long-term functioning was needed.
Medicare Advantage plans provide less intensive post-acute care, study finds Read More »
